1. Boulikas T, Vougiouka M (2003) Cisplatin and platinum drugs at the molecular level. Oncol Rep 10:1663–1682
2. DeSoize B, Madoulet C (2002) Particular aspects of platinum compounds, used at present in cancer treatment. Crit Rev Oncol Hematol 42:317–325
3. Freshney RI (1999) Freshney’s culture of animal cells—A multimedia guide CD-ROM. Wiley-Liss, New York
4. Hanigan MH, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1:47–61
5. Karaivanova MH, Tcholakova YF, Bakalova AG, Aleksiev BV (1988) Antitumor action and some structure–activity relationships of new platinum(II) complexes with carboxylic ligands. Comp Rend Acad Bulg Sci 41:133–135